We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
-13.56%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.69%
AUM
$1.06B
AUM Growth
-$347M
Cap. Flow
-$169M
Cap. Flow %
-15.94%
Top 10 Hldgs %
20.31%
Holding
216
New
27
Increased
45
Reduced
64
Closed
43

Top Buys

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$17.7M
2
THS
Treehouse Foods
THS
+$15.3M
3
CUTR
Cutera, Inc.
CUTR
+$15.2M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$14.1M
5
BJ icon
BJs Wholesale Club
BJ
+$12.7M

Top Sells

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$21.1M
2
RRR icon
Red Rock Resorts
RRR
+$17.2M
3
PACW
PacWest Bancorp
PACW
+$16.1M
4
BROS icon
Dutch Bros
BROS
+$15M
5
SDGR icon
Schrodinger
SDGR
+$12.5M

Sector Composition

Rank Sector Weight
1 Healthcare 40.95%
2 Technology 16.49%
3 Energy 7.85%
4 Industrials 7.52%
5 Consumer Staples 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARGX icon
1
argenx
ARGX
$52B
$30.3M 2.87%
80,025
-16,335
-17% -$5.26M
ITCI
2
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$24.8M 2.34%
433,959
-128,414
-23% -$7.28M
EXE
3
Expand Energy Corp
EXE
$21.9B
$24.5M 2.31%
301,589
-49,469
-14% -$4.47M
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$20M 1.89%
137,306
-38,977
-22% -$4.98M
PODD icon
5
Insulet
PODD
$11.8B
$20M 1.89%
91,603
-2,491
-3% -$566K
WSC icon
6
WillScot Mobile Mini Holdings
WSC
$4.66B
$19.7M 1.87%
609,114
-5,312
-0.9% -$188K
ESTA icon
7
Establishment Labs
ESTA
$2.73B
$19.6M 1.86%
361,015
+24,623
+7% +$1.56M
SWAV
8
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$19.2M 1.82%
+100,503
New +$17.7M
HQY icon
9
HealthEquity
HQY
$8.72B
$18.6M 1.76%
303,179
-11,525
-4% -$738K
RGEN icon
10
Repligen
RGEN
$8.3B
$18.2M 1.72%
111,779
-5,208
-4% -$824K
MPWR icon
11
Monolithic Power Systems
MPWR
$66B
$17.6M 1.66%
45,844
-11,076
-19% -$4.68M
VRTX icon
12
Vertex Pharmaceuticals
VRTX
$119B
$17.5M 1.65%
62,069
– –
ESI icon
13
Element Solutions
ESI
$9.18B
$17.4M 1.65%
979,104
-178,595
-15% -$3.62M
THS
14
DELISTED
Treehouse Foods
THS
$17.4M 1.65%
+416,437
New +$15.3M
HZNP
15
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$17.1M 1.62%
214,277
-25,648
-11% -$2.43M
NARI
16
DELISTED
Inari Medical, Inc. Common Stock
NARI
$16.7M 1.58%
246,292
+25,117
+11% +$1.81M
XOM icon
17
ExxonMobil
XOM
$643B
$16.5M 1.56%
193,000
-20,710
-10% -$1.87M
RXDX
18
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$15M 1.42%
531,293
+344,213
+184% +$9.98M
KRYS icon
19
Krystal Biotech
KRYS
$9.21B
$15M 1.41%
227,877
-855
-0.4% -$53.2K
LSCC icon
20
Lattice Semiconductor
LSCC
$18B
$14.1M 1.33%
289,802
-105,016
-27% -$5.23M
RARE icon
21
Ultragenyx Pharmaceutical
RARE
$2.46B
$13.7M 1.29%
+229,492
New +$14.1M
MSFT icon
22
Microsoft
MSFT
$3.62T
$13.5M 1.28%
52,646
-9,135
-15% -$2.48M
CVX icon
23
Chevron
CVX
$385B
$13.4M 1.27%
92,700
-19,000
-17% -$3.14M
BJ icon
24
BJs Wholesale Club
BJ
$12.4B
$12.6M 1.19%
+202,325
New +$12.7M
ISEE
25
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$12.4M 1.17%
1,290,053
+196,377
+18% +$2.46M
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Nicholas Investment Partners held 216 positions worth $1.06B, down 25% from $1.41B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Investment Partners withdrew a net $169M in Q2 2022, closing 43 positions and reducing 64 holdings. Its most notable exit was Avantor, an estimated $21.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Technology and Energy.

Against the trend, Nicholas Investment Partners opened a new position in Shockwave Medical, Inc. Common Stock worth $19.2M.

  • Nicholas Investment Partners's largest Q2 2022 buy was Shockwave Medical, Inc. Common Stock: 100,503 shares worth $19.2M.
  • Nicholas Investment Partners added most to Prometheus Biosciences, Inc. Common Stock in Q2 2022, an estimated $9.98M increase.
  • Nicholas Investment Partners's biggest Q2 2022 reduction was Diamondback Energy, cutting an estimated $8.93M.
  • Nicholas Investment Partners fully exited Avantor in Q2 2022, selling an estimated $21.1M.
  • Nicholas Investment Partners's ten largest holdings make up 20% of its $1.06B portfolio in Q2 2022.
  • Nicholas Investment Partners opened 27 new positions and closed 43 in Q2 2022.
  • Nicholas Investment Partners's portfolio value fell 25% quarter-over-quarter to $1.06B.

Based on Nicholas Investment Partners's 13F filing for Q2 2022, filed 10 Aug 2022.